Cfm Wealth Partners LLC Lumos Pharma, Inc. Transaction History

Cfm Wealth Partners LLC

  • $541 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020
SELL
$13.25 - $16.5 $649 - $808
-49 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$7.76 - $16.99 $380 - $832
49 New
49 $1,000

Others Institutions Holding LUMO

# of Institutions
41
Shares Held
2.19M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $30.6M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Cfm Wealth Partners LLC Portfolio

Follow Cfm Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfm Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfm Wealth Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email